Get started
Altimmune, Inc.Altimmune, Inc.Altimmune, Inc.

Altimmune, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

ALT trade ideas

ALT Reversal Incoming? +Trade Setup (>168% Profit Potential)Hello Fellow Traders, Today we are looking at Altimmune Inc (ALT) on the NASDAQ. We can see that on the last bullish wave, prices peaked at around $35. We can see since then a bullish continuation pattern, the falling wedge, has been printed. The price has broken out to the upside, retested the EMAs for support, and bounced back to consolidate just in the $11.75-$12.50 range.W Now, with prices above all EMAs, we can expect additional growth. We can use a larger buy range for this stock because the risk-to-reward is very good. If prices begin an uptrend here, it is a good time to go long. In the long run, a breakout past the ATH of $35 has a Fib target of $52! If you think this is unrealistic, take a look at my last idea on SOLO down below. However, a potential short-mid-term trade set up now could be: Entry: $11.50-$13.75 Targets: $24.00 (+80%) | $35 (+$1.68%) | $52 (+297%). Stop loss: daily close below $10.50 (-10%). Let me know what you guys think down below and leave a like if you appreciate the analysis. Also, check out some of my other ideas and follow my profile for more chart analyses and profitable trade setups! Thanks for reading :) Price at writing: $12.98
NASDAQ:ALTLong
by PS_TopDollarInvestments
MACD & STOCH RSI POSITIVE LEGAL DISCLAIMER : This is NOT AN INVESTMENT ADVICE ! It is intended to be used and must be used for informational & educational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, or independently research and verify, any information that you find on our Website and wish to rely upon, whether for the purpose of making an investment decision or otherwise.
NASDAQ:ALTLong
by Trade_Expert_
Altimmune, Inc. Breakout TargetsAltimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.
NASDAQ:ALTLong
by DEXWireNews